1.735
3.89%
0.065
전일 마감가:
$1.67
열려 있는:
$1.66
하루 거래량:
1.06M
Relative Volume:
0.23
시가총액:
$718.97M
수익:
$4.78B
순이익/손실:
$-284.68M
주가수익비율:
-7.8864
EPS:
-0.22
순현금흐름:
$-184.84M
1주 성능:
+1.46%
1개월 성능:
-38.26%
6개월 성능:
-68.74%
1년 성능:
-84.23%
애질론 헬스 Stock (AGL) Company Profile
명칭
Agilon Health Inc
전화
562-256-3800
주소
6210 E HWY 290, AUSTIN
AGL을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
AGL | 1.73 | 718.97M | 4.78B | -284.68M | -184.84M | -0.22 |
HCA | 326.91 | 83.79B | 69.62B | 5.93B | 5.88B | 20.33 |
THC | 146.07 | 14.83B | 20.97B | 3.13B | 2.39B | 4.33 |
DVA | 163.01 | 13.19B | 12.67B | 827.68M | 1.42B | 5.03 |
UHS | 193.59 | 13.03B | 15.42B | 1.03B | 956.84M | 9.53 |
FMS | 21.85 | 12.79B | 20.87B | 715.19M | 2.10B | 0.8156 |
애질론 헬스 Stock (AGL) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-01-08 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
2024-01-08 | 다운그레이드 | Stifel | Buy → Hold |
2024-01-08 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
2024-01-05 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2024-01-05 | 다운그레이드 | Truist | Buy → Hold |
2023-12-11 | 다운그레이드 | Goldman | Buy → Neutral |
2023-12-06 | 개시 | JMP Securities | Mkt Outperform |
2023-11-21 | 다운그레이드 | Deutsche Bank | Buy → Hold |
2023-10-20 | 개시 | The Benchmark Company | Buy |
2023-06-13 | 개시 | Evercore ISI | In-line |
2022-12-09 | 개시 | Stifel | Buy |
2022-09-14 | 개시 | RBC Capital Mkts | Outperform |
2022-09-12 | 개시 | Goldman | Buy |
2022-09-07 | 재개 | Truist | Buy |
2022-06-24 | 개시 | BTIG Research | Neutral |
2022-03-30 | 개시 | Guggenheim | Buy |
2021-10-20 | 개시 | Jefferies | Buy |
2021-09-27 | 개시 | SVB Leerink | Outperform |
2021-09-10 | 개시 | Cowen | Outperform |
2021-05-11 | 개시 | William Blair | Outperform |
2021-05-10 | 개시 | BofA Securities | Buy |
2021-05-10 | 개시 | Deutsche Bank | Buy |
2021-05-10 | 개시 | Goldman | Buy |
2021-05-10 | 개시 | JP Morgan | Overweight |
2021-05-10 | 개시 | Truist | Buy |
2021-05-10 | 개시 | Wells Fargo | Overweight |
2021-05-10 | 개시 | Wolfe Research | Outperform |
모두보기
애질론 헬스 주식(AGL)의 최신 뉴스
agilon health's (AGL) Outperform Rating Reaffirmed at Royal Bank of Canada - MarketBeat
Agilon Health to Present Growth Plans at Conference - TipRanks
Agilon Health price target lowered to $4 from $8 at Wells Fargo - Yahoo Finance
agilon health (NYSE:AGL) Reaches New 12-Month Low After Analyst Downgrade - MarketBeat
Leerink Partnrs Forecasts Weaker Earnings for agilon health - MarketBeat
Capital World Investors Reduces Stake in Agilon Health Inc - GuruFocus.com
Q1 EPS Estimates for agilon health Cut by Leerink Partnrs - MarketBeat
agilon health (NYSE:AGL) Trading Down 7.9% on Analyst Downgrade - MarketBeat
agilon health Reports ACO REACH Model Results for 2023 Performance Year - Business Wire
Agilon Health's SWOT analysis: stock struggles amid Medicare Advantage challenges - Investing.com India
Agilon Health stock downgraded to market perform after 3Q earnings miss - Investing.com Australia
Agilon Health stock target cut, hold rating on EBITDA miss - Investing.com India
Agilon Health stock target cut, hold rating on EBITDA miss By Investing.com - Investing.com Canada
agilon health (NYSE:AGL) Given New $2.00 Price Target at TD Cowen - MarketBeat
Barclays Has Lowered Expectations for agilon health (NYSE:AGL) Stock Price - MarketBeat
agilon health, inc. (NYSE:AGL) Q3 2024 Earnings Call Transcript - Insider Monkey
agilon health (NYSE:AGL) Rating Lowered to "Market Perform" at JMP Securities - MarketBeat
This Celanese Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday - Benzinga
Earnings call: agilon health reports mixed Q3 results amid strategic shifts - Investing.com Nigeria
agilon health, inc. (NYSE:AGL) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St
William Blair downgrades agilon health stock, cites profit pressures By Investing.com - Investing.com Nigeria
agilon health Plunges On A Poor Prognosis (Rating Downgrade) (NYSE:AGL) - Seeking Alpha
Agilon Health Shares Dive 31% on Plans to Exit Contracts, Wider 3Q Loss - MarketWatch
Wellington Management Group LLP Adjusts Stake in Agilon Health I - GuruFocus.com
agilon health (NYSE:AGL) Sets New 1-Year LowShould You Sell? - MarketBeat
agilon cut to market perform by William Blair on Q3 earnings report - MSN
The Analyst Landscape: 3 Takes On Agilon Health - Benzinga
agilon cut to market perform by William Blair on Q3 earnings report (NYSE:AGL) - Seeking Alpha
Agilon Health (AGL) Reports Q3 Loss, Lags Revenue Estimates - MSN
agilon health (NYSE:AGL) Rating Lowered to "Market Perform" at William Blair - MarketBeat
William Blair downgrades agilon health stock, cites profit pressures - Investing.com India
Agilon Health shares plunge 28% on weak Q3 results, lowered guidance - Investing.com India
Agilon Health Inc (AGL) Q3 2024 Earnings Call Highlights: Revenue Surge Amidst Margin Challenges By GuruFocus - Investing.com Canada
Agilon: Q3 Earnings Snapshot - The Washington Post
Agilon Health Reports Growth Amidst Financial Challenges - TipRanks
Here's What Key Metrics Tell Us About Agilon (AGL) Q3 Earnings - Yahoo Finance
Agilon Health shares plunge 28% on weak Q3 results, lowered guidance By Investing.com - Investing.com South Africa
agilon health earnings missed by $0.19, revenue fell short of estimates - Investing.com UK
agilon health Reports Third Quarter 2024 Results - Business Wire
Morgan Stanley's Strategic Reduction in Agilon Health Inc Shares - GuruFocus.com
agilon health to Participate at 2024 Wolfe Research Healthcare Conference - Business Wire
Brokerages Set agilon health, inc. (NYSE:AGL) Target Price at $7.81 - MarketBeat
AGILON HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against agilon health - AccessWire
agilon health (AGL) Set to Announce Earnings on Thursday - MarketBeat
agilon cut to sell at Citi on Medicare headwinds - MSN
agilon stock cut to sell at Citi on Medicare (AGL:NYSE) - Seeking Alpha
AGILON ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
AGILON ALERT: Bragar Eagel & Squire, P.C. is Investigating Agilon Health, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
agilon health's (AGL) "Sell" Rating Reiterated at Citigroup - MarketBeat
Citi cuts agilon health to sell, slashes target to $2.50 from $7 - Investing.com India
애질론 헬스 (AGL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):